Clinical trial
Combination Chemotherapy in Treating Patients With Previously Untreated Stage…
NCT00003378 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00003378 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer |
| Official title | A Phase I Feasibility Trial of Carboplatin, Paclitaxel, and Gemcitabine in Patients With Previously Untreated Epithelial Ovarian Carcinoma and Primary Peritoneal Carcinoma |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, gemcitabine hydrochloride, paclitaxel |
| Enrollment | 45 |
| Start date | Aug 1, 1998 |
| Primary completion | Feb 1, 2000 |
| First posted | Aug 26, 2004 |
| Last update posted | Jul 9, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: